GL64
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C27H19Cl3N2O2 |
| Molar mass | 509.81 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
GL64 is a chemical compound which acts as an agonist at the androgen receptor GPR133. It increases bone density by inhibiting osteoclastogenesis, and shows beneficial effects in an animal model of osteoporosis.[1]
See also
References
- ^ He L, Zhang Q, You Y, Sun P, Xu Z, Li R, et al. (July 2025). "Exogenous activation of the adhesion GPCR ADGRD1/GPR133 protects against bone loss by negatively regulating osteoclastogenesis". Science Advances. 11 (28) eads3829. doi:10.1126/sciadv.ads3829. PMC 12248284. PMID 40644539.